Patents by Inventor Thea Dunzo

Thea Dunzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE FORMULATION OF NALTREXONE
    Publication number: 20070281021
    Abstract: A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.
    Type: Application
    Filed: June 4, 2007
    Publication date: December 6, 2007
    Applicant: OREXIGEN THERAPEUTICS, INC.
    Inventors: Anthony McKinney, Gary Tollefson, Richard Soltero, Thea Dunzo